Most importantly, the overexpression of SSTR5’s truncated form, sst5TMD4, in breast cancer model increases the pro-angiogenic factors, as well as the number of blood vessels, and is associated with the proliferation of and treatment response to SST analogs [72]. Here, SSTR5 is linked to breast carcinoma.